Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.16), $0.12 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $38.85 million.

“During the third quarter we were pleased to see increased momentum in both long-standing and new areas of our business,” said Lynne Laube, CEO & Co-Founder of Cardlytics. “We are also excited about the incremental strides we have made towards the future version of our platform, and we see great opportunity for our clients, both directly and via agencies.”

“Despite the challenging environment, we continue to see our business track in the right direction month after month,” said Andy Christiansen, CFO of Cardlytics. “In addition to our improving results, we also completed a $230 million convertible notes offering, which will support general corporate purposes, as well as potential acquisitions and strategic transactions to further the growth of our business.”

For earnings history and earnings-related data on Cardlytics (CDLX) click here.